Breaking News Instant updates and real-time market news.

CMCSA

Comcast

$33.28

(0.00%)

, FOXA

21st Century Fox

$37.32

(0.00%)

09:22
04/19/18
04/19
09:22
04/19/18
09:22

Comcast bid for Fox not comparable to Disney's, CNBC reports

Comcast's (CMCSA) rejected $34.41 per share bid for the assets of 21st Century Fox (FOX) is not comparable to Disney's (DIS) winning bid due to, among other things, put-back provisions and a stipulation that Fox can't pay a dividend before the deal closes, CNBC's David Faber reports, citing sources. Fox rejected Comcast's bid due to antitrust concerns and its lack of deal protections, Faber adds.

CMCSA

Comcast

$33.28

(0.00%)

FOXA

21st Century Fox

$37.32

(0.00%)

DIS

Disney

$101.21

(0.00%)

  • 25

    Apr

  • 08

    May

  • 09

    May

CMCSA Comcast
$33.28

(0.00%)

04/09/18
NOMU
04/09/18
NO CHANGE
Target $40
NOMU
Neutral
Comcast price target lowed to $40 from $45 at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal lowered his price target for Comcast shares to $40 to reflect reduced buyback expectations. The analyst, however, says the "sky is not falling." The analyst, while continuing to prefer mobile over fixed, views the 15% pullback in Comcast shares as an overreaction. He expects the company to offer investors "some relief" on its Q1 call. Kvaal keeps a Neutral rating on Comcast.
03/26/18
COWN
03/26/18
INITIATION
COWN
Market Perform
Comcast initiated with a Market Perform at Cowen
03/15/18
LOOP
03/15/18
INITIATION
Target $43
LOOP
Buy
21st Century Fox initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started 21st Century Fox (FOXA) with a Buy rating and $43 price target. The analyst believes the company is set up as the "ideal acquisition target for either Disney (DIS) or Comcast (CMCSA) as they evolve their video businesses into a global, direct-to-consumer streaming service."
04/02/18
MACQ
04/02/18
NO CHANGE
Target $38
MACQ
Neutral
Macquarie sees Q1 video losses for Comcast
Macquarie analyst Amy Yong is modeling Comcast Q1 video net losses of 77k and revenue declines of .7% due to lower video net adds/ARPU. Yong expects downward estimate revisions for Comcast given headwinds to the video business and uncertainty around its interest in Sky and lowered her 2018/19 consolidated EBITDA to $29.2B and $31.2B, respectively. The analyst rates shares of Comcast a Neutral and cut her price target to $38 from $42.
FOXA 21st Century Fox
$37.32

(0.00%)

03/07/18
WELS
03/07/18
NO CHANGE
WELS
Wells Fargo expects bidding war for Sky
Wells Fargo analyst Marci Ryvicker expects a bidding war for Sky (SKYAY). The analyst believes Sky appears to be more accretive to Disney (DIS)-Fox (FOXA) but more strategic for Comcast (CMCSA; CMCSK). Ultimately, Ryvicker thinks the latter with win but not without a fight from Disney/Fox.
03/14/18
MACQ
03/14/18
UPGRADE
MACQ
Outperform
Sky upgraded to Outperform from Neutral at Macquarie
Macquarie analyst Guy Peddy upgraded Sky (SKYAY) to Outperform from Neutral after he raised his FY19/20 and FY20/21 EPS by about 16% due to the lower EPL costs. His valuation analysis suggests the current 1075p offer from 21st Century Fox (FOXA) "materially undervalues" Sky and even Comcast's (CMCSA) indicative offer at 1250p "fractionally undervalues" it, Peddy tells investors. What happens next is up to Comcast and Disney (DIS), as Fox is just an intermediary, he added. Peddy raised his price target on Sky shares to 1450p, as he believes tension between those two could lift the offer price at least 10% above his fair value estimate of 1287p.
03/15/18
LOOP
03/15/18
INITIATION
Target $130
LOOP
Buy
Disney initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started Disney (DIS) with a Buy rating and $130 price target. The analyst views the Disney/21st Century Fox (FOXA) deal as a "win/win," positioning Disney to be a more competitive player in the global streaming business.
DIS Disney
$101.21

(0.00%)

04/17/18
PIVT
04/17/18
UPGRADE
Target $93
PIVT
Hold
Disney upgraded to Hold from Sell at Pivotal Research
Pivotal Research analyst Brian Wieser upgraded Disney to Hold while trimming his price target for the shares to $93 from $94. The company "has a lot of positive elements" heading into the back half of the year, including a strong film slate, the launch of new direct to consumer over-the-top services and efforts in support of the close of the Fox (FOXA) transaction, Wieser tells investors in a research note. The analyst believes all the stocks he covers in the video-centric media space look fairly valued.
04/11/18
JPMS
04/11/18
NO CHANGE
JPMS
JPMorgan boosts Disney estimates on 'Black Panther' strength
To reflect the strength of "Blank Panther," JPMorgan analyst Alexia Quadrani raised her Q2 earnings per share estimate for Disney to $1.68 from $1.57. The move has grossed $1.3B in global box office to date, far above the analyst's previous $775M estimate. The "significant outperformance" of "Black Panther" more than offsets softer results for "A Wrinkle in Time," Quadrani tells investors in a research note. The analyst is currently Not Rated on shares of Disney.
04/17/18
04/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Hold from Sell at Pivotal Research with analyst Brian Wieser saying the company "has a lot of positive elements" heading into the back half of the year, including a strong film slate, the launch of new direct to consumer over-the-top services, and efforts in support of the close of the Fox (FOXA) transaction. 2. Coca-Cola (KO) upgraded to Neutral from Sell at Goldman Sachs with analyst Judy Hong saying she sees an improving organic sales growth outlook, "cleaner base" post-refranchising, and better visibility on its margin and earnings targets. 3. Merck (MRK) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying the Keytruda+chemo combination showed better than expected results in lung cancer, boosting the company's immuno-oncology lead against Bristol-Myers (BMY). 4. Newell Brands (NWL) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog saying the stock's setup is good looking forward, with greater potential upside than downside risk over the next 12 months. 5. Twitter (TWTR) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Brian Nowak citing recent advertiser conversations that have continued to be incrementally positive about Twitter's ad business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MB

Mindbody

$41.05

1 (2.50%)

07:43
09/19/18
09/19
07:43
09/19/18
07:43
Recommendations
Mindbody analyst commentary  »

Mindbody price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNLO

Menlo Therapeutics

$10.68

0.07 (0.66%)

07:43
09/19/18
09/19
07:43
09/19/18
07:43
Conference/Events
Menlo Therapeutics management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

SPWR

SunPower

$7.55

0.97 (14.74%)

07:41
09/19/18
09/19
07:41
09/19/18
07:41
Upgrade
SunPower rating change  »

SunPower upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCRA

Vocera

$33.51

0.01 (0.03%)

07:41
09/19/18
09/19
07:41
09/19/18
07:41
Initiation
Vocera initiated  »

Jefferies starts Vocera…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

JNPR

Juniper

$28.60

0.6 (2.14%)

07:37
09/19/18
09/19
07:37
09/19/18
07:37
Upgrade
Juniper rating change  »

Nomura upgrades Juniper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 11

    Oct

  • 16

    Oct

BWA

BorgWarner

$42.99

-1.17 (-2.65%)

07:37
09/19/18
09/19
07:37
09/19/18
07:37
Recommendations
BorgWarner analyst commentary  »

BorgWarner price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

NOK

Nokia

$5.62

0.125 (2.27%)

07:36
09/19/18
09/19
07:36
09/19/18
07:36
Downgrade
Nokia rating change  »

Nokia downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$181.58

1.8 (1.00%)

07:35
09/19/18
09/19
07:35
09/19/18
07:35
Conference/Events
MarketAxess management to meet with Compass Point »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

PBR

Petrobras

$11.23

0.305 (2.79%)

, TLRY

Tilray

$154.99

34.79 (28.94%)

07:35
09/19/18
09/19
07:35
09/19/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

PBR

Petrobras

$11.23

0.305 (2.79%)

TLRY

Tilray

$154.99

34.79 (28.94%)

STZ

Constellation Brands

$213.44

1.24 (0.58%)

FIT

Fitbit

$5.80

0.35 (6.42%)

DLTR

Dollar Tree

$85.20

-0.3 (-0.35%)

EDU

New Oriental Education

$67.58

-1.22 (-1.77%)

UNP

Union Pacific

$163.70

6.97 (4.45%)

ETE

Energy Transfer Equity

$17.39

0.08 (0.46%)

SGMS

Scientific Games

$26.40

1.525 (6.13%)

YELP

Yelp

$49.98

3.695 (7.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 04

    Oct

  • 10

    Oct

  • 13

    Oct

  • 28

    Oct

  • 06

    Nov

CCXI

ChemoCentryx

$11.51

1.01 (9.62%)

07:35
09/19/18
09/19
07:35
09/19/18
07:35
Recommendations
ChemoCentryx analyst commentary  »

ChemoCentryx weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

07:35
09/19/18
09/19
07:35
09/19/18
07:35
General news
U.S. MBA mortgage market index rose 1.6% »

U.S. MBA mortgage market…

ATHN

Athenahealth

$135.25

-8.005 (-5.59%)

07:34
09/19/18
09/19
07:34
09/19/18
07:34
Recommendations
Athenahealth analyst commentary  »

Athenahealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$85.29

2.04 (2.45%)

07:34
09/19/18
09/19
07:34
09/19/18
07:34
Recommendations
Nike analyst commentary  »

Morgan Stanley says Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 25

    Sep

AIHS

Senmiao Technology

$5.10

-0.12 (-2.30%)

07:32
09/19/18
09/19
07:32
09/19/18
07:32
Hot Stocks
Senmiao Technology names Xiaoyuan Zhang as CFO, succeeding Rong Zhu »

Senmiao Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOK

Nokia

$5.62

0.125 (2.27%)

07:32
09/19/18
09/19
07:32
09/19/18
07:32
Upgrade
Nokia rating change  »

Nokia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEPT

Neptune Technologies

$4.26

0.045 (1.07%)

07:31
09/19/18
09/19
07:31
09/19/18
07:31
Hot Stocks
Neptune Technologies approves name change to Neptune Wellness Solutions »

Neptune Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$77.70

0.67 (0.87%)

, SEAS

SeaWorld

$31.20

0.02 (0.06%)

07:30
09/19/18
09/19
07:30
09/19/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

BBY

Best Buy

$77.70

0.67 (0.87%)

SEAS

SeaWorld

$31.20

0.02 (0.06%)

BGS

B&G Foods

$30.30

-1.25 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 06

    Nov

QCOM

Qualcomm

$74.73

1.48 (2.02%)

07:30
09/19/18
09/19
07:30
09/19/18
07:30
Recommendations
Qualcomm analyst commentary  »

Qualcomm price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:30
09/19/18
09/19
07:30
09/19/18
07:30
General news
Treasury Market Outlook: yields cheapened overnight »

Treasury Market Outlook:…

JMP

JMP Group

$5.31

0.015 (0.28%)

07:29
09/19/18
09/19
07:29
09/19/18
07:29
Conference/Events
JMP Group management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

EGN

Energen

$79.34

1.2 (1.54%)

07:29
09/19/18
09/19
07:29
09/19/18
07:29
Downgrade
Energen rating change  »

Energen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$241.58

-14.22 (-5.56%)

07:27
09/19/18
09/19
07:27
09/19/18
07:27
Conference/Events
FedEx management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 03

    Oct

  • 04

    Oct

SBRA

Sabra Health Care

$23.32

-0.04 (-0.17%)

07:26
09/19/18
09/19
07:26
09/19/18
07:26
Initiation
Sabra Health Care initiated  »

Sabra Health Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IOTS

Adesto Technologies

$6.05

-0.05 (-0.82%)

07:26
09/19/18
09/19
07:26
09/19/18
07:26
Recommendations
Adesto Technologies analyst commentary  »

Adesto Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 09

    Oct

NBIX

Neurocrine

$120.32

3.03 (2.58%)

07:25
09/19/18
09/19
07:25
09/19/18
07:25
Recommendations
Neurocrine analyst commentary  »

Cantor more confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.